EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting insulin and leptin in obesity management: A case series in metabolic health practice

Jeffrey R. Pua, Melanie M. Tidman, Dawn R. White, Tim A. White

Journal of Metabolic Health · 2026

DOI: 10.4102/jmh.v9i1.148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Metabolic Health, 2026. Verfasst von Jeffrey R. Pua und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A low-carbohydrate ketogenic (LCK) diet implemented in a metabolic health practice was evaluated for its association with changes in fasting hyperinsulinemia, fasting hyperleptinemia and other metabolic biomarkers in adults with obesity. Six adults with obesity were recruited from the Duly Weight Loss Clinic in Westmont, Illinois, between 2022 and 2025. The cohort comprised three men and three women with a body mass index (BMI) > 30 kg/m2 who followed an LCK diet without anti-obesity pharmacotherapy. Participants were monitored for 12 months with visits every 30–60 days that included counselling, coaching and fasting beta-hydroxybutyrate checks. Outcomes measured were changes in body weight, fasting insulin, fasting leptin and haemoglobin A1c (HbA1c). All six participants achieved clinically meaningful weight loss over 12 months. Mean weight reduction was 25% from baseline. Fasting insulin decreased by a mean of 15.3 mIU/L, representing a 64% reduction. Fasting leptin decreased by a mean of 25.5 ng/mL, corresponding to an 80% reduction. Haemoglobin A1c decreased by a mean of 0.27%. Weight reduction was accompanied by reductions in fasting insulin and fasting leptin, while HbA1c remained relatively stable. An LCK dietary approach combined with structured lifestyle support was associated with substantial weight loss and reductions in fasting insulin and circulating leptin, with HbA1c remaining relatively stable over 12 months. These findings support further investigation of an LCK diet within structured outpatient obesity management. An LCK diet within a structured obesity medicine programme was associated with clinically meaningful weight loss and reductions in fasting insulin and leptin concentrations.

Zitieren

APA

Pua, J. R., Tidman, M. M., White, D. R., & White, T. A. (2026). Targeting insulin and leptin in obesity management: A case series in metabolic health practice. Journal of Metabolic Health. https://doi.org/10.4102/jmh.v9i1.148

Vancouver

Pua JR, Tidman MM, White DR, White TA. Targeting insulin and leptin in obesity management: A case series in metabolic health practice. Journal of Metabolic Health. 2026. doi:10.4102/jmh.v9i1.148

BibTeX
@article{Pua2026,
  author = {Pua, Jeffrey R. and Tidman, Melanie M. and White, Dawn R. and White, Tim A.},
  title = {Targeting insulin and leptin in obesity management: A case series in metabolic health practice},
  journal = {Journal of Metabolic Health},
  year = {2026},
  doi = {10.4102/jmh.v9i1.148}
}
Kostenlos starten →